Gilead Sciences (GILD) Tops Q2 EPS by 56c
Tweet
Share
E-mail
Get Alerts GILD Hot Sheet
Price: $143.72 --0%
Revenue Growth %: -0.3%
Financial Fact:
Net loss attributable to noncontrolling interest: -5M
Today's EPS Names:
OCCI, VIVO, PMCB, More
Revenue Growth %: -0.3%
Financial Fact:
Net loss attributable to noncontrolling interest: -5M
Today's EPS Names:
OCCI, VIVO, PMCB, More
Join SI Premium – FREE
Gilead Sciences (NASDAQ: GILD) reported Q2 EPS of ($6.75), $0.56 better than the analyst estimate of ($7.31). Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.4 billion.
For earnings history and earnings-related data on Gilead Sciences (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wall Street's new pair trade: Long software, short chips
- MaxLinear (MXL) Reiterated at Buy by StoneX on Earnings Growth Potential
- Amerigo Declares Cdn$0.21 per share Performance Dividend
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
